Dr. Galina S. Marder, MD

Dr. Marder practices at Northwell Health Physician Partners Cardiology in Great Neck, New York.

Dr. Marder's NPI, 1851470058, was assigned on November 6, 2006. Dr. Marder holds New York license 207505.

Dr. Marder's primary practice is Northwell Health Physician Partners Cardiology, at 865 Northern Blvd, Great Neck, NY 11021 in Nassau County. The practice phone is (516) 321-7400.

Dr. Marder's primary practice is Northwell Health Physician Partners Cardiology in Great Neck, New York. Dr. Marder is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Marder to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marder practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Marder's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Marder is licensed in New York.

CMS data shows 1,712 Medicare services from Dr. Marder across 17 procedure codes in 2024, for 218 Medicare patients. Medicare paid $93,548 for them.

CMS counts 218 Medicare patients who saw Dr. Marder in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marder's median patient age at 63, with 74% women.

In 2024, Dr. Marder wrote 1,916 Medicare Part D claims for 224 patients. 84% of them were for generic drugs. CMS names the drug for 1,693 of them, across 39 drugs with 11 or more claims each, at $1,766,504 in total drug cost. In 2023, CMS named 1,540 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Marder for performance year 2024, reported through an alternative payment model (APM). Dr. Marder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marder as offering telehealth.

Dmand AI links 15 papers to Dr. Marder, published from 2016 to 2025. 2017 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Humanized, COVID-19 and Immunosuppressive Agents. Dr. Marder has published most often in Rheumatology (Oxford). Dr. Marder's most frequent co-authors are Sonali Narain, MD, Rohit Aggarwal, MD and Siamak Moghadam-Kia, MD, MPH.

Dmand AI links Dr. Marder to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Dermatomyositis and Polymyositis.

CMS Open Payments shows 34 general payments to Dr. Marder from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $11,304.